Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Eli Lilly (LLY), and highlights the potential misalignment of interests between brokerage firms and retail investors [1][10]. Brokerage Recommendations - Eli Lilly currently has an average brokerage recommendation (ABR) of 1.55, indicating a consensus between Strong Buy and Buy, based on recommendations from 28 brokerage firms [2]. - Out of the 28 recommendations, 19 are classified as Strong Buy, accounting for 67.9%, while 2 are classified as Buy, making up 7.1% of the total [2]. Limitations of Brokerage Recommendations - The article suggests that relying solely on brokerage recommendations may not be wise, as studies indicate limited success in guiding investors towards stocks with the best price increase potential [5]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, often issuing five "Strong Buy" recommendations for every "Strong Sell" [6][10]. Zacks Rank as an Alternative - Zacks Rank is presented as a more effective tool for predicting stock price movements, categorizing stocks into five groups based on earnings estimate revisions [8][11]. - The Zacks Rank is distinct from ABR, as it is based on quantitative models rather than solely on brokerage recommendations, and is updated more frequently to reflect current market conditions [9][12]. Current Earnings Estimates for Eli Lilly - The Zacks Consensus Estimate for Eli Lilly's current year earnings has declined by 1.8% over the past month to $22.73, indicating growing pessimism among analysts regarding the company's earnings prospects [13]. - This decline in earnings estimates has resulted in a Zacks Rank of 4 (Sell) for Eli Lilly, suggesting caution despite the positive ABR [14].

Core Insights - Wall Street analysts' recommendations significantly influence investors' decisions regarding Norwegian Cruise Line (NCLH) stock, with an average brokerage recommendation (ABR) of 1.64 indicating a preference for buying the stock [2][5]. Brokerage Recommendations - The current ABR of 1.64 is based on 22 brokerage firms, with 15 firms (68.2%) issuing a "Strong Buy" recommendation [2]. - Despite the positive ABR, reliance solely on brokerage recommendations may not be advisable, as studies indicate they often fail to guide investors effectively towards stocks with high price appreciation potential [5][10]. Analyst Bias - Brokerage analysts tend to exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of favorable ratings compared to negative ones [6][10]. - For every "Strong Sell" recommendation, there are five "Strong Buy" recommendations, suggesting a misalignment of interests between brokerage firms and retail investors [6][7]. Zacks Rank vs. ABR - The Zacks Rank, a proprietary stock rating tool, is based on earnings estimate revisions and is considered a more reliable indicator of near-term price performance compared to ABR [8][11]. - The Zacks Rank is updated more frequently and reflects the latest earnings estimates, while ABR may not always be current [12]. Earnings Estimates for NCLH - The Zacks Consensus Estimate for NCLH has increased by 3.1% over the past month to $2.1, indicating growing optimism among analysts regarding the company's earnings prospects [13]. - This increase in consensus estimates, along with other factors, has resulted in a Zacks Rank of 1 (Strong Buy) for Norwegian Cruise Line, suggesting a potential for stock price appreciation [14].

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Roku (ROKU) .Roku currently has an average brokerage recommendation (ABR) of 1.84, on a scale o ...

Core Viewpoint - Wall Street analysts' recommendations, while influential on stock prices, may not reliably guide investors in selecting stocks with the highest potential for price appreciation [3][4][8]. Summary by Sections Brokerage Recommendations - Archrock Inc. (AROC) has an average brokerage recommendation (ABR) of 1.60, indicating a position between Strong Buy and Buy, based on recommendations from 10 brokerage firms [2]. - The breakdown of recommendations shows six as Strong Buy (60%) and two as Buy (20%) [2]. Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations often lack success in guiding investors towards stocks with significant price appreciation potential [3]. - Analysts from brokerage firms tend to exhibit a positive bias due to vested interests, resulting in a disproportionate number of favorable ratings compared to negative ones [4][8]. Zacks Rank as an Alternative - Zacks Rank, a proprietary stock rating tool, categorizes stocks from Strong Buy to Strong Sell and is based on earnings estimate revisions, which correlate strongly with near-term stock price movements [6][9]. - The Zacks Rank is distinct from ABR, as it is a quantitative model rather than solely based on brokerage recommendations [7]. Current Earnings Estimates for Archrock Inc. - The Zacks Consensus Estimate for Archrock Inc. remains unchanged at $1.57 for the current year, suggesting stable analyst views on the company's earnings prospects [11]. - The Zacks Rank for Archrock Inc. is currently 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [12].

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Workday (WDAY), and emphasizes the importance of validating these recommendations with other indicators like the Zacks Rank [1][5]. Brokerage Recommendations - Workday has an average brokerage recommendation (ABR) of 1.59, indicating a consensus between Strong Buy and Buy, based on 39 brokerage firms [2]. - Out of the 39 recommendations, 26 are Strong Buy (66.7%) and 3 are Buy (7.7%) [2]. Limitations of Brokerage Recommendations - Solely relying on ABR for investment decisions may not be wise, as studies show limited success in guiding investors towards stocks with the best price increase potential [5]. - Analysts from brokerage firms often exhibit a strong positive bias due to vested interests, leading to a disproportionate number of Strong Buy recommendations compared to Strong Sell [6][10]. Zacks Rank as an Alternative - The Zacks Rank, which classifies stocks from 1 (Strong Buy) to 5 (Strong Sell), is presented as a more reliable indicator of near-term price performance, driven by earnings estimate revisions [8][11]. - The Zacks Rank is timely and reflects the latest earnings estimates, unlike the ABR, which may not be up-to-date [13]. Workday's Earnings Estimates - The Zacks Consensus Estimate for Workday's current year earnings has increased by 7.5% over the past month to $8.84, indicating growing optimism among analysts [14]. - The recent change in consensus estimates, along with other factors, has resulted in a Zacks Rank 1 (Strong Buy) for Workday, suggesting a potential for stock price appreciation [15].

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Chipotle Mexican Grill (CMG), and highlights the potential misalignment of interests between brokerage analysts and retail investors [1][5][10]. Brokerage Recommendations - Chipotle has an average brokerage recommendation (ABR) of 1.56, indicating a position between Strong Buy and Buy, based on recommendations from 33 brokerage firms [2]. - Out of the 33 recommendations, 22 are classified as Strong Buy (66.7%) and 3 as Buy (9.1%) [2]. Limitations of Brokerage Recommendations - Solely relying on brokerage recommendations for investment decisions may not be advisable, as studies indicate they often fail to guide investors effectively towards stocks with high price appreciation potential [5][10]. - Brokerage analysts tend to exhibit a strong positive bias in their ratings due to vested interests, leading to a disproportionate number of favorable ratings compared to negative ones [6][10]. Zacks Rank as an Alternative - Zacks Rank, a proprietary stock rating tool, categorizes stocks from Strong Buy to Strong Sell and is based on earnings estimate revisions, which have shown a strong correlation with near-term stock price movements [8][11]. - The Zacks Rank is distinct from ABR, as it is a quantitative model that reflects timely earnings estimates, while ABR may not always be up-to-date [9][12]. Current Earnings Estimates for Chipotle - The Zacks Consensus Estimate for Chipotle's current year earnings remains unchanged at $1.21, suggesting analysts have steady views on the company's earnings prospects [13]. - Due to the unchanged consensus estimate and other factors, Chipotle holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [14].

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Cardinal Health (CAH) . Cardinal currently has an average broker ...

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Merck (MRK), and highlights the potential misalignment of interests between brokerage firms and retail investors [1][5][10]. Brokerage Recommendations for Merck - Merck has an average brokerage recommendation (ABR) of 1.92, indicating a consensus between Strong Buy and Buy, based on 25 brokerage firms [2]. - Out of the 25 recommendations, 13 are Strong Buy (52%) and 1 is Buy (4%) [2]. Limitations of Brokerage Recommendations - The article suggests that relying solely on brokerage recommendations may not be wise, as studies indicate limited success in guiding investors towards stocks with the best price increase potential [5]. - Brokerage firms often exhibit a strong positive bias in their ratings due to vested interests, leading to a disproportionate number of favorable ratings compared to negative ones [6][10]. Zacks Rank as an Alternative - Zacks Rank, a proprietary stock rating tool, categorizes stocks into five groups and is based on earnings estimate revisions, which have shown a strong correlation with near-term stock price movements [8][11]. - The Zacks Rank is distinct from ABR, as it is a quantitative model that reflects timely earnings estimates, while ABR may not be up-to-date [9][12]. Current Earnings Estimates for Merck - The Zacks Consensus Estimate for Merck's earnings has declined by 0.9% over the past month to $8.85, indicating growing pessimism among analysts regarding the company's earnings prospects [13]. - This decline in consensus estimates has resulted in a Zacks Rank of 4 (Sell) for Merck, suggesting caution despite the favorable ABR [14].

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Wingstop (WING), and emphasizes the importance of using these recommendations in conjunction with other analytical tools like the Zacks Rank for making informed investment decisions [1][5][10]. Brokerage Recommendations - Wingstop has an average brokerage recommendation (ABR) of 1.59, indicating a consensus between Strong Buy and Buy, based on recommendations from 23 brokerage firms [2]. - Out of the 23 recommendations, 15 are classified as Strong Buy and 2 as Buy, which represent 65.2% and 8.7% of all recommendations respectively [2]. Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations have limited success in guiding investors towards stocks with the highest price increase potential [5]. - Brokerage firms often exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of Strong Buy recommendations compared to Strong Sell [6][10]. Zacks Rank vs. ABR - The Zacks Rank is a proprietary tool that classifies stocks based on earnings estimate revisions, providing a more reliable indicator of near-term price performance compared to ABR [8][11]. - The Zacks Rank is updated more frequently and reflects timely changes in earnings estimates, while ABR may not always be current [12]. Current Earnings Estimates for Wingstop - The Zacks Consensus Estimate for Wingstop's earnings for the current year remains unchanged at $3.9, suggesting stable analyst views on the company's earnings prospects [13]. - Due to the unchanged consensus estimate and other factors, Wingstop holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [14].

Core Viewpoint - The average brokerage recommendation (ABR) for Norwegian Cruise Line (NCLH) is 1.64, indicating a general suggestion to buy the stock, but reliance solely on this metric may not be advisable due to potential biases in brokerage recommendations [2][5][10]. Group 1: Brokerage Recommendations - NCLH has an ABR of 1.64, which is between Strong Buy and Buy, based on recommendations from 22 brokerage firms, with 15 of those being Strong Buy, representing 68.2% of all recommendations [2]. - Despite the positive ABR, studies suggest that brokerage recommendations often do not effectively guide investors toward stocks with the highest potential for price appreciation [5][10]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings due to vested interests, leading to a disproportionate number of favorable ratings compared to negative ones [6][10]. Group 2: Zacks Rank vs. ABR - The Zacks Rank, which ranges from 1 (Strong Buy) to 5 (Strong Sell), is a quantitative model based on earnings estimate revisions and is considered a more reliable indicator of near-term stock performance compared to ABR [8][9]. - The Zacks Rank is updated more frequently and reflects changes in earnings estimates promptly, making it a timely tool for predicting future price movements [13]. - For NCLH, the Zacks Consensus Estimate for the current year has decreased by 0.1% to $2.03, indicating growing pessimism among analysts regarding the company's earnings prospects [14]. Group 3: Current Investment Outlook - The recent decline in the consensus estimate and other related factors have resulted in a Zacks Rank of 5 (Strong Sell) for NCLH, suggesting caution despite the Buy-equivalent ABR [15].